NASDAQ$TECX

Tectonic Therapeutic Inc · Q2 2023 earnings

Q2 2023 earnings · · Investor relations

Headline financials

Total Revenue

$23K

Previous: $0.00
EPS (adj)

$1.52

Previous: -$0.64+337.5%
Net Loss Per Share

-$8.51

Previous: -$0.64-1229.7%
Capital Expenditures

-$8K

Previous: $149K-105.4%
Free Cash Flow

$67.5M

Previous: -$29.3M+330.6%
Net Income

$67.5M

Previous: -$28.1M+340.5%
Operating Income

$68M

Previous: -$27.8M+344.9%
Gross Profit

-$659K

No prior period
Cash & Equivalents

$125M

Previous: $132M-5.8%
Total Assets

$134M

Previous: $146M-8.5%
Stock-Based Comp

$1.53M

Previous: $3.23M-52.6%

Revenue & EPS history

Tectonic · Revenue · Quarterly

$23K

Q2 2023

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 17 quarterly earnings reports · overlaid with Q2 2023

Historical avgQ2 2023

-1.4%

Avg return

Earnings day

-1.0%

Avg return

5 days after

+2.9%

Avg return

30 days after

41%

7 / 17 earnings

Positive

+11.1%

Q4 2021

Best reaction

-20.3%

Q4 2022

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2025-2.4%+14.5%+22.6%
Q3 2025+1.5%-0.7%+4.9%
Q1 2025-0.9%+3.5%-13.4%
Q4 2024+1.0%-11.8%+11.0%
Q3 2024-2.0%+6.5%+14.8%
Q1 2024+0.0%-0.8%-7.0%
Q4 2023+0.8%-2.3%-1.6%
Q3 2023-9.9%-13.2%-7.2%
Q2 2023+0.6%-1.9%+4.5%
Q1 2023-4.5%-4.5%+82.1%
Q4 2022-20.3%-14.6%-23.6%
Q3 2022-1.5%+12.1%+19.7%
Q2 2022+5.0%+5.9%-12.9%
Q1 2022-7.3%-1.2%+30.5%
Q4 2021+11.1%+12.5%-20.8%
Q3 2021-1.0%-3.8%-40.7%
Q2 2021+6.5%-17.0%-13.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro